Clinical Trial: A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate

Brief Summary: This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.

Detailed Summary: To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face
Sponsor: Bayer

Current Primary Outcome: Sum Score of the symptoms of seborrheic dermatitis and the investigator's global assessment. [ Time Frame: Measurement of parameters during the course of treatment (six weeks) ]

Original Primary Outcome:

Current Secondary Outcome: Investigators' and patients' subjective assessment of improvement; frequency and intensity of single symptoms [ Time Frame: Measurement of parameters during the course of treatment (six weeks) ]

Original Secondary Outcome:

Information By: Bayer

Dates:
Date Received: December 5, 2006
Date Started: December 2006
Date Completion:
Last Updated: March 18, 2015
Last Verified: March 2015